SCHEMBL6720857

SCHEMBL6720857

O=C(c1cc(I)c(O)c(I)c1)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
L3MBTL1 Q9Y468 1/20 0.56
TSHR P16473 3/20 0.53
HDAC3 O15379 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
CFTR P13569 2/20 0.50
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
CTSL P07711 1/20 0.46
CTSS P25774 1/20 0.46
PPARG P37231 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6725133 0.92 LMNA (0.55) KMT2AMEN1L3MBTL1TSHRHDAC1
SCHEMBL6725022 0.87 KMT2A (0.69) KMT2AMEN1TSHRHDAC1HDAC6
SCHEMBL6724972 0.82 PPARG (0.46) KMT2AMEN1TSHRHDAC1HDAC6
SCHEMBL8359492 0.80 KMT2A (0.76) KMT2AMEN1L3MBTL1TSHRHDAC3
SCHEMBL1003508 0.80 HDAC1 (0.71) KMT2AMEN1L3MBTL1TSHRHDAC3
SCHEMBL28778954 0.80 KMT2A (0.65) KMT2AMEN1L3MBTL1TSHRHDAC3
SCHEMBL10724882 0.78 KMT2A (0.73) KMT2AMEN1L3MBTL1TSHRHDAC3
Oxalic Acid SCHEMBL29264737 0.77 HDAC1 (0.67) KMT2AMEN1L3MBTL1TSHRHDAC3
Oxalic Acid SCHEMBL29264739 0.77 HDAC1 (0.67) KMT2AMEN1L3MBTL1TSHRHDAC3
SCHEMBL3456064 0.76 KMT2A (0.70) KMT2AMEN1L3MBTL1TSHRHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677473-B1 TREATMENT, PREVENTION OR AMELIORATION OF ONE OR MORE SYMPTOMS OF THROMBOTIC DISORDERS, UNSTABLE ANGINA OR CANCER CORVAS INTERNATIONAL INC 2004-01-13 US disclosed
WO-2001036351-A2 PLASMINOGEN ACTIVATOR INHIBITOR ANTAGONISTS RELATED APPLICATIONS CORVAS INTERNATIONAL, INC. (US) 2001-05-25 WO disclosed